Published in Cancer Metastasis Rev on January 01, 2001
A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome. Proc Natl Acad Sci U S A (2007) 1.44
Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem (2008) 1.40
A glycomics platform for the analysis of permethylated oligosaccharide alditols. J Am Soc Mass Spectrom (2007) 1.38
Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res (2009) 1.30
Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data. Bioinformatics (2008) 1.28
A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem (2010) 1.27
Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res (2009) 1.26
Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J (2004) 1.23
Development of a robust and high throughput method for profiling N-linked glycans derived from plasma glycoproteins by NanoLC-FTICR mass spectrometry. J Proteome Res (2009) 1.19
Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients. Anal Chem (2009) 1.17
Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer (2007) 1.16
Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays. Anal Chem (2011) 1.15
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res (2011) 1.11
Protein glycosylation in cancer. Annu Rev Pathol (2015) 1.11
Stable-isotope labeled hydrophobic hydrazide reagents for the relative quantification of N-linked glycans by electrospray ionization mass spectrometry. Anal Chem (2011) 1.07
Selective enrichment of sialic acid-containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry. Nat Protoc (2010) 1.07
Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin Exp Metastasis (2005) 1.03
Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers. Theranostics (2015) 0.96
Lectin of Concanavalin A as an anti-hepatoma therapeutic agent. J Biomed Sci (2009) 0.96
Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system. Mol Cell Proteomics (2008) 0.91
A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancer. Electrophoresis (2011) 0.89
Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. Int J Oncol (2010) 0.89
Direct targeting of cancer cells: a multiparameter approach. Acta Histochem (2005) 0.88
Analysis of differential expression of glycosyltransferases in healing corneas by glycogene microarrays. Glycobiology (2009) 0.88
The sweet and sour of serological glycoprotein tumor biomarker quantification. BMC Med (2013) 0.88
Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. Acta Histochem (2007) 0.87
Vascular diffusion density and survival of patients with primary lung carcinomas. Virchows Arch (2003) 0.86
One-Year Plasma N-linked Glycome Intra-individual and Inter-individual Variability in the Chicken Model of Spontaneous Ovarian Adenocarcinoma. Int J Mass Spectrom (2011) 0.85
Analysis of unconventional approaches for the rapid detection of surface lectin binding ligands on human cell lines. Acta Histochem (2006) 0.83
Real-time and label-free analysis of binding thermodynamics of carbohydrate-protein interactions on unfixed cancer cell surfaces using a QCM biosensor. Sci Rep (2015) 0.82
Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells. Radiat Oncol (2012) 0.82
Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry. BMC Cancer (2008) 0.82
Analysis and prediction of cancerlectins using evolutionary and domain information. BMC Res Notes (2011) 0.82
Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity. Mol Cell Biochem (2009) 0.81
Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention. Eur J Nutr (2011) 0.81
Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue. Clin Proteomics (2015) 0.80
Beta1-6 branching of cell surface glycoproteins may contribute to uveal melanoma progression by up-regulating cell motility. Mol Vis (2008) 0.80
Characterization of protein aggregation via intrinsic fluorescence lifetime. J Am Chem Soc (2009) 0.79
Inhibition binding studies of glycodendrimer-lectin interactions using surface plasmon resonance. Tetrahedron (2010) 0.78
Structural separations by ion mobility-MS for glycomics and glycoproteomics. Methods Mol Biol (2013) 0.78
Photo- and biophysical studies of lectin-conjugated fluorescent nanoparticles: reduced sensitivity in high density assays. J Phys Chem B (2010) 0.78
Unprecedented glycosidase activity at a lectin carbohydrate-binding site exemplified by the cyanobacterial lectin MVL. J Am Chem Soc (2009) 0.78
L1CAM from human melanoma carries a novel type of N-glycan with Galβ1-4Galβ1- motif. Involvement of N-linked glycans in migratory and invasive behaviour of melanoma cells. Glycoconj J (2012) 0.77
Enhanced N-glycosylation site exploitation of sialoglycopeptides by peptide IPG-IEF assisted TiO2 chromatography. Glycoconj J (2012) 0.77
Photophysics of glycosylated derivatives of a chlorin, isobacteriochlorin and bacteriochlorin for photodynamic theragnostics: discovery of a two-photon-absorbing photosensitizer. Photochem Photobiol (2013) 0.77
CHST11/13 Regulate the Metastasis and Chemosensitivity of Human Hepatocellular Carcinoma Cells Via Mitogen-Activated Protein Kinase Pathway. Dig Dis Sci (2016) 0.76
Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis. PLoS One (2015) 0.76
Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors. Eur Arch Otorhinolaryngol (2005) 0.76
Active Targeting to Osteosarcoma Cells and Apoptotic Cell Death Induction by the Novel Lectin Eucheuma serra Agglutinin Isolated from a Marine Red Alga. J Drug Deliv (2012) 0.75
Synthesis and anti-tumor activity of carbohydrate analogues of the tetrahydrofuran containing acetogenins. Bioorg Med Chem (2013) 0.75
Jacalin-Activated Macrophages Exhibit an Antitumor Phenotype. Biomed Res Int (2016) 0.75
Interaction between some monosaccharides and aspartic acid in dilute aqueous solutions. J Biol Phys (2008) 0.75
Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers. Prostate Cancer (2013) 0.75
Porifera Lectins: Diversity, Physiological Roles and Biotechnological Potential. Mar Drugs (2015) 0.75
Anti-Neuroblastoma Properties of a Recombinant Sunflower Lectin. Int J Mol Sci (2017) 0.75
Plant Lectins as Medical Tools against Digestive System Cancers. Int J Mol Sci (2017) 0.75
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature (1985) 6.86
Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest (1968) 3.52
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem (1990) 3.34
Influence of preoperative anxiety on hypotension after spinal anaesthesia in women undergoing Caesarean delivery. Br J Anaesth (2012) 3.29
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
Thromboxanes: selective biosynthesis and distinct biological properties. Science (1976) 2.46
Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues. J Exp Med (1985) 2.37
Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates. Proc Natl Acad Sci U S A (1987) 2.27
Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res (1997) 2.22
The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. J Immunol (1974) 2.19
Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci (1998) 2.17
Impact of community educational programmes on foreign body aspiration in Israel. Eur J Pediatr (1995) 2.09
Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci U S A (1979) 2.07
Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol (2000) 1.97
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst (1995) 1.92
The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J Biol Chem (1969) 1.88
Studies on the protein-protein and protein-ligand interactions involved in retinol transport in plasma. J Biol Chem (1970) 1.68
Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. J Clin Invest (1977) 1.63
Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry (1994) 1.63
Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res (1999) 1.60
On the role of galectin-3 in cancer apoptosis. Apoptosis (2005) 1.60
Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. Proc Natl Acad Sci U S A (1977) 1.56
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res (2001) 1.55
The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res (1999) 1.51
Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. Science (1977) 1.47
Galectin-3 stimulates cell proliferation. Exp Cell Res (1998) 1.44
Platelet and blood vessel arachidonate metabolism and interactions. J Clin Invest (1979) 1.44
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res (1982) 1.41
Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res (1996) 1.41
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res (1996) 1.39
The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J Exp Med (1987) 1.38
Characterization of a novel metabolic pathway of arachidonate in coronary arteries which generates a potent endogenous coronary vasodilator. J Biol Chem (1977) 1.37
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res (1982) 1.32
Interaction of prostaglandins with blood plasma proteins. Comparative binding of prostaglandins A 2 , F 2 and E 2 to human plasma proteins. Biochem J (1972) 1.32
Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am J Physiol (1977) 1.32
Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology (1998) 1.28
Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation. Biochem Biophys Res Commun (1989) 1.28
Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer (1995) 1.25
Activated T cells in the synovial fluid of arthritic patients: characterization and comparison with in vitro activated human and murine T cells in cooperation with monocytes in cytotoxicity. J Immunol (1979) 1.24
Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. J Pharmacol Exp Ther (1998) 1.24
Radioimmunoassay of human plasma retinol-binding protein. J Clin Invest (1970) 1.24
Selective incorporation of 14C-arachidonic acid into the phospholipids of intact tissues and subsequent metabolism to 14C-prostaglandins. Prostaglandins (1976) 1.24
Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res (1980) 1.23
Lectin-like activities associated with human and murine neoplastic cells. Cancer Res (1981) 1.23
Speech sounds learned by sleeping newborns. Nature (2002) 1.23
Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest (1992) 1.22
Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J (1994) 1.21
The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett (1999) 1.21
Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest (2000) 1.20
Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr (2001) 1.20
Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. Am J Pathol (2001) 1.19
Motility and adhesive properties of high- and low-metastatic murine neoplastic cells. Cancer Res (1984) 1.19
Aspirated foreign bodies in the respiratory tract of children: eleven years experience with 127 patients. Int J Pediatr Otorhinolaryngol (1994) 1.19
Distribution of Gal alpha 1----3Gal beta 1----4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay. Biochemistry (1990) 1.19
Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res (1998) 1.19
Bradykinin and angiotensin II activation of arachidonic acid deacylation and prostaglandin E2 formation in rabbit kidney. Hormone-sensitive versus hormone-insensitive lipid pools of arachidonic acid. J Biol Chem (1981) 1.18
Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase. Xenotransplantation (1998) 1.18
A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart. Proc Natl Acad Sci U S A (1977) 1.15
Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest (1986) 1.15
Morphological study of fully and partially isolated early human follicles. Fertil Steril (2001) 1.13
Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J Immunol (1989) 1.13
Hormonal stimulation of arachidonate release from isolated perfused organs. Relationship to prostaglandin biosynthesis. Prostaglandins (1977) 1.13
Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res (1990) 1.13
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem (1991) 1.12
Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity. J Immunol (1975) 1.11
Endoperoxides and thromboxanes. Structural determinants for platelet aggregation and vasoconstriction. Biochim Biophys Acta (1977) 1.11
Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res (1981) 1.11
Multinucleation and inhibition of cytokinesis in suspended cells: reversal upon reattachment to a substrate. Cell (1981) 1.10
The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer (1976) 1.09
Differential expression of alpha-GAL epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs. Transplantation (2000) 1.09
Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol (2001) 1.09
Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res (1995) 1.08
Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids. Cancer Res (1982) 1.08
Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line. Int J Oncol (1995) 1.07
Decreased galectin-3 expression in prostate cancer. Prostate (2000) 1.07
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res (1994) 1.06
Electrospray/tandem mass spectrometry for quantitative analysis of lipid remodeling in essential fatty acid deficient mice. Anal Biochem (2000) 1.05
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol (1992) 1.05
Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. Cancer Res (1999) 1.04
Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein. Biochim Biophys Acta (2000) 1.04
Cell surface properties of B16 melanoma variants with differing metastatic potential. Cancer Res (1980) 1.04
Lectins in cancer cells. Ann N Y Acad Sci (1988) 1.03
Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res Treat (1998) 1.03
Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. J Biol Chem (1987) 1.02
Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer (1999) 1.02
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment. Cell Death Dis (2010) 1.02
Purinergic vs peptidergic stimulation of lipolysis and prostaglandin generation in the perfused rabbit kidney. Biochem Pharmacol (1982) 1.02
Lectin-induced apoptosis of tumour cells. Glycobiology (1993) 1.02
Structure-function relationship of a recombinant human galactoside-binding protein. Biochemistry (1993) 1.02
Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection. Cancer Res (1995) 1.01
Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res (1996) 1.01
Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis (1997) 1.01
Age-associated changes in subpopulations of human lymphocytes. Clin Immunol Immunopathol (1977) 1.01
Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst (1992) 1.01
Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer (2002) 1.01
Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity. Int J Cancer (1989) 1.00
Natural species-restricted attachment of human and murine T lymphocytes to various cells. Proc Natl Acad Sci U S A (1978) 1.00